These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6205521)

  • 1. [Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro].
    Stöckmann F; Göke B; Otto J; Lankisch PG; Creutzfeldt W
    Z Gastroenterol; 1984 Jun; 22(6):311-7. PubMed ID: 6205521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
    Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
    Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulative effect of a casein hydrolysate on exocrine pancreatic secretion that is independent of luminal trypsin inhibitory activity in rats.
    Hira T; Hara H; Aoyama Y
    Biosci Biotechnol Biochem; 1999 Jul; 63(7):1192-6. PubMed ID: 10478447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of endogenous cholecystokinin released by bombesin and trypsin inhibitor on the regeneration of the pancreas.
    Parekh D; Ishizuka J; Townsend CM; Rajaraman S; Thompson JC
    Ann Surg; 1993 Dec; 218(6):735-41. PubMed ID: 8257223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous administration of the synthetic trypsin inhibitor Foy-305 induces hypertrophy of the exocrine pancreas.
    Wereszczyńska-Siemiatkowska U; Pohl U; Otto J; Lankisch PG
    Digestion; 1987; 37(3):144-8. PubMed ID: 2443410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory responses of hypertrophied rat pancreas induced by repeated oral administrations of a synthetic protease inhibitor.
    Yonezawa H
    Jpn J Physiol; 1983; 33(2):183-95. PubMed ID: 6876500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes.
    Layer P; Jansen JB; Cherian L; Lamers CB; Goebell H
    Gastroenterology; 1990 May; 98(5 Pt 1):1311-9. PubMed ID: 2323522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General and selective inhibition of pancreatic enzyme discharge using a proteinase inhibitor (FOY-305).
    Adler G; Rausch U; Weidenbach F; Arnold R; Kern HF
    Klin Wochenschr; 1984 May; 62(9):406-11. PubMed ID: 6202931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate).
    Adler G; Müllenhoff A; Koop I; Bozkurt T; Göke B; Beglinger C; Arnold R
    Eur J Clin Invest; 1988 Feb; 18(1):98-104. PubMed ID: 3130267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in pattern of enzyme secretion by rat pancreas during repeated trypsin inhibitor treatment.
    Keim V; Göke B; Adler G
    Am J Physiol; 1988 Aug; 255(2 Pt 1):G236-41. PubMed ID: 2457325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
    Schädlich HR; Büchler M; Beger HG
    Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of camostat, a synthetic protease inhibitor, on endocrine and exocrine pancreas of the rat.
    Müller MK; Goebell H; Alfen R; Ehlers J; Jäger M; Plümpe H
    J Nutr; 1988 May; 118(5):645-50. PubMed ID: 2452864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. I. Dose-response study on enzyme content and secretion, cholecystokinin release and pancreatic fine structure.
    Rausch U; Adler G; Weidenbach H; Weidenbach F; Rudolff D; Koop I; Kern HF
    Cell Tissue Res; 1987 Jan; 247(1):187-93. PubMed ID: 2435411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.
    Freise J; Magerstedt P; Schmid K
    Enzyme; 1983; 30(3):209-12. PubMed ID: 6194983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
    Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW
    Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular mechanism responsible for reduced enzyme secretion from camostate-induced hypertrophied pancreas.
    Herzig KH; May D; Louie DS; Takahashi T; Göke B; Owyang C
    Digestion; 1990; 46 Suppl 2():195-201. PubMed ID: 1702070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
    Freise J
    Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of atropine on feedback regulation of pancreatic secretion in rats.
    Weidenbach H; Printz H; Göke B; Koop I; Schafmayer A; Adler G
    Res Exp Med (Berl); 1989; 189(3):221-8. PubMed ID: 2473503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. II. Regulation of total protein and individual enzyme biosynthesis.
    Rausch U; Weidenbach H; Adler G; Kern HF
    Cell Tissue Res; 1987 Jul; 249(1):63-7. PubMed ID: 2441868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.